P532 Safety and efficacy of endoscopic dilation of small bowel Crohn’s disease strictures by balloon-assisted enteroscopy: pooled analysis of individual data from 210 patients
D. Bettenworth*1, A. Bokemeyer1, L. Kou2, R. Lopez2, B. P. Halloran3, M. Reeson3, S. Hosomi4, M. Kishi5, F. Hirai5, N. Ohmiya6, F. Rieder7,8
1University Hospital Münster, Department of Medicine B, Gastroenterology and Hepatology, Münster, Germany, 2Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland, USA, 3University of Alberta, Division of Gastroenterology, Edmonton, Canada, 4Osaka City University Graduate School of Medicine, Department of Gastroenterology, Osaka, Japan, 5Fukuoka University Chikushi Hospital, Chikushino, Inflammatory Bowel Disease Center, Fukuoka, Japan, 6Fujita Health University School of Medicine, Department of Gastroenterology, Toyoake city, Japan, 7Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland, USA, 8Cleveland Clinic Foundation, Department of Pathobiology, Lerner Research Institute, Cleveland, USA
Strictures are a common complication of Crohn’s disease (CD). While colonoscopy has been proven suitable and effective for dilation therapy of CD-associated strictures of the ileocaecum, the published evidence on safety and efficacy of balloon-assisted enteroscopy (BAE) for balloon dilation therapy of CD strictures of the small intestine is scarce. We therefore performed a pooled safety and efficacy based on individual patient data.
A systematic literature review was performed to assess all relevant citations found in Embase, Medline and the Cochrane library regarding BAE used for EBD of small intestinal CD strictures. In addition, conference proceedings including DDW, ECCO, UEGW, A-IBD, AGA and German Gastroenterology Congress were screened for additional data. Study authors were contacted to provide individual patient data. Descriptive statistics were used to summarise patients’ characteristics. Univariate cox proportional hazards regression model was applied to find out possible risk factors for need for re-dilation and surgery. Backward model selection procedure was used and multi-variate cox model were built.
19 publications with a total of 468 CD patients and 1194 performed dilation procedures were included. 25.1% of strictures were anastomotic strictures (74.9% de novo,, respectively). Technical success rate was 88.1%, resulting in clinical efficacy in 78% of patients. Major complications defined as perforation, bleeding or dilation-related surgery occurred in 3.7% of all procedures. During a mean follow-up period of 16 months, 45.7 of patients reported symptomatic recurrence, while 38.1% of patients needed to undergo re-dilation and 27.5% required surgical intervention.
Multi-variate analysis of 210 individual patients identified a 56% higher hazard of re-dilation in CD patients with symptomatic recurrence compared with asymptomatic patients and a 60% higher hazard in patients with prestenotic dilation compared with patients with no prestenotic dilation. Additionally, increased CRP values at dilation (elevation of CRP per 0.1 increased the hazard for surgery by 9.3%) and inflamed mucosa at dilation (4 times increased hazard when compared with non-inflamed mucosa) were identified as risk factors for the need for surgery.